Nonclinical assessment of repeated dosing of AZR-MD-001 to the lower eyelid (Selenium Sulphide, SeS2, sterile ophthalmic ointment): A novel therapy being developed for meibomian gland dysfunction

AZR-MD-001 - Azura Ophthalmics

Limor Miara 3; Glenwood G. Gum 1; Luba Litinetsky 3; Kathleen Krenzer 2; Linda Manza 1; Charles Bosworth 3; Yair Alster 3; Hila Epstin-Barash 3

Apr 6, 2023